首页> 美国卫生研究院文献>Human Gene Therapy Methods >A New Method for Generating Insulin-Secreting Cells from Human Pancreatic Epithelial Cells After Islet Isolation Transformed by NeuroD1
【2h】

A New Method for Generating Insulin-Secreting Cells from Human Pancreatic Epithelial Cells After Islet Isolation Transformed by NeuroD1

机译:从NeuroD1转化胰岛分离后从人胰腺上皮细胞生成胰岛素分泌细胞的新方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The generation of insulin-secreting cells from nonendocrine pancreatic epithelial cells (NEPEC) has been demonstrated for potential clinical use in the treatment of diabetes. However, previous methods either had limited efficacy or required viral vectors, which hinder clinical application. In this study, we aimed to establish an efficient method of insulin-secreting cell generation from NEPEC without viral vectors. We used nonislet fractions from both research-grade human pancreata from brain-dead donors and clinical pancreata after total pancreatectomy with autologous islet transplantation to treat chronic pancreatitis. It is of note that a few islets could be mingled in the nonislet fractions, but their influence could be limited. The NeuroD1 gene was induced into NEPEC using an effective triple lipofection method without viral vectors to generate insulin-secreting cells. The differentiation was promoted by adding a growth factor cocktail into the culture medium. Using the research-grade human pancreata, the effective method showed high efficacy in the differentiation of NEPEC into insulin-positive cells that secreted insulin in response to a glucose challenge and improved diabetes after being transplanted into diabetic athymic mice. Using the clinical pancreata, similar efficacy was obtained, even though those pancreata suffered chronic pancreatitis. In conclusion, our effective differentiation protocol with triple lipofection method enabled us to achieve very efficient insulin-secreting cell generation from human NEPEC without viral vectors. This method offers the potential for supplemental insulin-secreting cell transplantation for both allogeneic and autologous islet transplantation.
机译:从非内分泌胰腺上皮细胞(NEPEC)产生胰岛素分泌细胞已被证明可用于治疗糖尿病。然而,先前的方法要么功效有限要么需要病毒载体,这阻碍了临床应用。在这项研究中,我们旨在建立一种无需病毒载体的NEPEC分泌胰岛素分泌细胞的有效方法。我们在全胰切除术与自体胰岛移植后使用了来自脑死亡供体的研究级人类胰腺和临床胰腺的非胰岛部分,以治疗慢性胰腺炎。值得注意的是,少数胰岛可能会混入非胰岛馏分中,但其影响可能会受到限制。在没有病毒载体的情况下,使用有效的三重脂质转染方法将NeuroD1基因诱导到NEPEC中,以产生胰岛素分泌细胞。通过向培养基中添加生长因子混合物来促进分化。使用研究级的人类胰腺,该有效方法在将NEPEC分化为胰岛素阳性细胞后表现出很高的效率,该细胞可响应葡萄糖挑战而分泌胰岛素,并在移植到糖尿病性无胸腺小鼠后改善了糖尿病。使用临床胰腺,即使那些胰腺患有慢性胰腺炎,也可以获得类似的功效。总之,我们的有效分化方案与三重脂质转染法使我们能够从没有病毒载体的人NEPEC中获得非常有效的胰岛素分泌细胞生成。这种方法为同种异体和自体胰岛移植提供了补充胰岛素分泌细胞的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号